Skip to main content
An official website of the United States government

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

Sponsor
M.D. Anderson Cancer Center
Status
Recruiting
NCT ID
NCT05411718
To learn about the effects of naproxen and aspirin on the normal colon in people with Lynch Syndrome.
Intervention
Aspirin, Naproxen
Condition
T Cells, Colorectal Cancer, Lynch Syndrome
Investigators
Eduardo Vilar-Sanchez, MD, Eduardo Vilar Sanchez, MD

See list of participating sites